How MedTech Companies Get Found in the Age of AI

What does discoverability look like for MedTech companies now that buyers are using ChatGPT, Claude, and Perplexity to find partners?

In this episode of MedTech Unboxed, Steve talks with Lorenzo about how digital discovery is changing for CDMOs, suppliers, and MedTech brands operating in regulated markets. They unpack the shift from relationship-led visibility to AI-assisted search, and why traditional SEO still matters, even as answer engines and AI recommendations become a bigger part of how companies get shortlisted. Lorenzo breaks down the difference between SEO, AEO, and GEO, explains why smaller specialized companies may have a real advantage right now, and shares why website structure, authority-building content, and strategic focus matter more than ever.

They also discuss why many capable companies remain effectively invisible online, how MedTech marketers should think about long-term content strategy, and why the old “spray and pray” approach is losing ground fast. For companies that want to be found for the right capabilities, by the right buyers, this conversation is a timely look at what’s changing and what to do about it.

What you’ll hear in this episode:

• Why MedTech discoverability is shifting from human-led relationships to digital and AI-led search
• Why SEO is still the foundation
• What AEO and GEO mean in practical terms
• How smaller MedTech companies can compete with larger brands
• Why website infrastructure matters more in the AI era
• How to build content around authority and specific capabilities
• Why being “good at everything” is becoming a weaker strategy online